Search Results - "Zhao, Tiansuo"

ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1β/NF-κB/ESE3 signalling axis.

Authors: Zhao, Tiansuo Xiao, Di Jin, Fanjie et al.

Source: British Journal of Cancer. Nov2022, Vol. 127 Issue 8, p1461-1472. 12p.

Integrated pretreatment stratification system for pancreatic cancer: combining anatomical resectability and tumor biological parameters.

Authors: Gao, Song Liang, Yuexiang Yu, Jun et al.

Source: Cancer Biology & Medicine. Nov2025, Vol. 22 Issue 11, p1406-1422. 26p.

Leptin upregulates telomerase activity and transcription of human telomerase reverse transcriptase in MCF-7 breast cancer cells

Authors: Ren, He Zhao, Tiansuo Wang, Xiuchao et al.

Source: Biochemical & Biophysical Research Communications. Mar2010, Vol. 394 Issue 1, p59-63. 5p.

Proteasome inhibitor MG132 suppresses pancreatic ductal adenocarcinoma-cell migration by increasing ESE3 expression.

Authors: Jin, Fanjie Xiao, Di Zhao, Tiansuo et al.

Source: Oncology Letters. Jan2020, Vol. 19 Issue 1, p858-868. 11p.

SCF, Regulated by HIF-1α, Promotes Pancreatic Ductal Adenocarcinoma Cell Progression.

Authors: Gao, Chuntao Li, Shasha Zhao, Tiansuo et al.

Source: PLoS ONE. Mar2015, Vol. 10 Issue 3, p1-14. 14p.

Prognostic Significance of C-Reactive Protein or Prealbumin in Pancreatic Ductal Adenocarcinoma.

Authors: Guo, Yu Dou, Yibo Ma, Xi et al.

Source: Journal of Surgical Research. Feb2025, Vol. 306, p543-553. 11p.

HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal adenocarcinoma.

Authors: Wang, Haotian Jia, Rujiang Zhao, Tiansuo et al.

Source: Cancer Letters. Jul2019, Vol. 453, p10-20. 11p.

Hypoxia inducible factor (HIF)-1[alpha] directly activates leptin receptor (Ob-R) in pancreatic cancer cells.

Authors: Ren, He Jia, Lingling Zhao, Tiansuo et al.

Source: Cancer Letters. Nov2014, Vol. 354 Issue 1, p172-180. 9p.

Stem cell factor is a novel independent prognostic biomarker for hepatocellular carcinoma after curative resection.

Authors: Wang, Xiuchao Ren, He Zhao, Tiansuo et al.

Source: Carcinogenesis. Oct2014, Vol. 35 Issue 10, p2283-2290. 8p.

Retraction notice to "HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal adenocarcinoma" [Cancer Lett. 453 (2019) 10–20].

Authors: Wang, Haotian Jia, Rujiang Zhao, Tiansuo et al.

Source: Cancer Letters. Apr2023, Vol. 558, pN.PAG-N.PAG. 1p.

CD73 induces gemcitabine resistance in pancreatic ductal adenocarcinoma: A promising target with non-canonical mechanisms.

Authors: Yu, Xiaozhou Liu, Weishuai Wang, Ziyang et al.

Source: Cancer Letters. Oct2021, Vol. 519, p289-303. 15p.

PERK-eIF2α-ERK1/2 axis drives mesenchymal-endothelial transition of cancer-associated fibroblasts in pancreatic cancer.

Authors: Cai, Wenrun Sun, Xugang Jin, Fanjie et al.

Source: Cancer Letters. Sep2021, Vol. 515, p86-95. 10p.

CypA, a Gene Downstream of HIF-1α, Promotes the Development of PDAC.

Authors: Zhang, Huan Chen, Jing Liu, Fenghua et al.

Source: PLoS ONE. Mar2014, Vol. 9 Issue 3, p1-11. 11p.

The nuclear condensates of ESE3/EHF induce cellular senescence without the associated inflammatory secretory phenotype in pancreatic ductal adenocarcinoma.

Authors: Zhou, Tianxing Yan, Jingrui Xu, Bohang et al.

Source: Cancer Letters. Feb2025, Vol. 611, pN.PAG-N.PAG. 1p.

HIF-2-dependent expression of stem cell factor promotes metastasis in hepatocellular carcinoma.

Authors: Wang, Xiuchao Dong, Jie Jia, Li et al.

Source: Cancer Letters. May2017, Vol. 393, p113-124. 12p.

Genome-wide CRISPR screen identifies MTA3 as an inducer of gemcitabine resistance in pancreatic ductal adenocarcinoma.

Authors: Wu, Liangliang Ge, Yi Yuan, Yudong et al.

Source: Cancer Letters. Nov2022, Vol. 548, pN.PAG-N.PAG. 1p.

Targeting GPR34 in damage-associated macrophages enhances anti-tumor immunity and the efficacy of Surufatinib in pancreatic cancer.

Authors: Guo X Liu Y Li T et al.

Source: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2026 Apr 28; Vol. 11 (1). Date of Electronic Publication: 2026 Apr 28.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE

Retraction Note: BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis.

Authors: Huang C Li H Xu Y et al.

Source: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2026 Jan 02; Vol. 11 (1), pp. 4. Date of Electronic Publication: 2026 Jan 02.

Publication Type: Journal Article; Retraction Notice

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE; In Process

Epithelial FOXP3 Orchestrates O-Glycosylated IL6 Secretion to Drive Pancreatic Fibrocarcinogenesis.

Authors: Gong R Wang J Ren M et al.

Source: Gastroenterology [Gastroenterology] 2026 Jun 23. Date of Electronic Publication: 2026 Jun 23.

Publication Type: Journal Article

Journal Info: Publisher: W.B. Saunders Country of Publication: United States NLM ID: 0374630 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0012 (Electronic) Linking ISSN: 00165085 NLM ISO Abbreviation: Gastroenterology Subsets: MEDLINE

Senescent cancer-associated fibroblasts drive early-stage lymph node metastasis in pancreatic cancer through lactate-mediated metabolic-epigenetic rewiring.

Authors: Zhou T Yan J Mao G et al.

Source: Cancer discovery [Cancer Discov] 2026 Mar 27. Date of Electronic Publication: 2026 Mar 27.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE